XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.26.1

LEASES | 3 Months Ended
--- | ---
Mar. 31, 2026
LEASES |
LEASES | 6. LEASES Long-Term Operating Leases San Diego, California Capricor leases 34,348 square feet of laboratory, manufacturing, and office space located at 10865 Road to the Cure, San Diego, California for our corporate headquarters from Altman Investment Co., LLC (the “Altman Lease”). The lease agreement commenced on October 1, 2021 for an initial lease term of five years. On February 26, 2025, the Company entered into a fourth lease amendment, where the rent is subject to a 3.0% annual rent increase commencing October 1, 2026 plus certain operating expenses and taxes. The fourth lease amendment extends the lease term to September 30, 2033, with an option to renew for an additional term of five years. The Company is not reasonably certain that it will exercise this option to renew and therefore it is not included in right-of-use assets and liabilities as of March 31, 2026. The Fourth Amendment commenced on July 1, 2025, which resulted in an increase of approximately $13.5 million in operating lease liabilities and $13.4 million in right-of-use assets. The Altman Lease, as amended, provides for a tenant improvement allowance from the landlord for a total of $1.3 million to be received in 2026. The Company has thus remeasured its lease liability and right-of-use assets to reflect such allowance. The Company is currently engaged in advanced discussions regarding a lease for a potential facility in San Diego, California intended to support expanded manufacturing and operational activities and serve as the Company’s anticipated corporate headquarters. Capricor has entered into a non-binding letter of intent relating to the potential transaction and is currently negotiating a proposed license agreement for a short-term occupancy arrangement as well as a potential long-term lease agreement. Any definitive transaction remains subject to execution of final agreements. Los Angeles, California Capricor leases 1,892 square feet of laboratory, manufacturing and office facilities in Los Angeles, California from CSMC, pursuant to a lease entered into in 2014. Capricor subsequently entered into several amendments modifying certain terms of the lease. We entered into an amendment effective August 1, 2024 for an additional 24-month period extending the term through July 31, 2026 with a monthly lease payment of $11,028. At this time, there is no intention of further extending the term of the lease and the Company will vacate the premises as of the termination date. The long-term real estate operating leases are included in “lease right-of-use assets, net” on the Company’s Consolidated Balance Sheet and represent the Company’s right-to-use the underlying assets for the lease term. The Company’s obligation to make lease payments are included in “lease liabilities, current” and “lease liabilities, net of current” on the Company’s Consolidated Balance Sheets. ​ The table below excludes short-term operating leases. The following table summarizes maturities of lease liabilities and the reconciliation of lease liabilities as of March 31, 2026: ​
​ | ​ | ​ | ​
2026 (remainder) | ​ | $ | 1,155,889
2027 | ​ | ​ | 2,411,889
2028 | ​ | ​ | 2,482,464
2029 | ​ | ​ | 2,555,156
2030 | ​ | ​ | 2,630,029
Thereafter | ​ | ​ | 7,629,341
Total minimum lease payments | ​ | ​ | 18,864,768
Less: imputed interest | ​ | ​ | (4,080,038)
Total operating lease liabilities | ​ | $ | 14,784,730
Included in the consolidated balance sheet: | ​ | ​ | ​
Current portion of lease liabilities | ​ | $ | 841,135
Lease liabilities, net of current | ​ | ​ | 13,943,595
Total operating lease liabilities | ​ | $ | 14,784,730
​ | ​ | ​ | ​
Other Information: | ​ | ​ | ​
Weighted average remaining lease term | ​ | ​ | 7.5 years
Weighted average discount rate | ​ | ​ | 6.3%
​ The following table contains a summary of the lease costs recognized and lease payments pertaining to the Company’s operating leases under ASC 842 for the period indicated: ​
​ | ​ | ​ | ​ | ​ | ​
​ | Three months ended March 31,
​ | 2026 | ​ ​ ​ | 2025
Operating lease costs | $ | 605,960 | ​ | $ | 210,357
Variable lease costs | ​ | 304,624 | ​ | ​ | 108,126
Lease payments | ​ | 614,675 | ​ | ​ | 227,201
​ Short-Term Operating Leases The Company has several short-term lease arrangements for laboratory, manufacturing, and office space in Beverly Hills, Vista, and San Diego, California, which either expired in January 2026 or have remaining lease terms between May 2026 and December 2026. Short-term operating lease cost for the three months ended March 31, 2026 and 2025 were $286,294 and $369,178, respectively.

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-20/tableOfContent + Details
Name: | us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration